Extent and time course of morphological changes of bone marrow induced by granulocyte‐colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors
Open Access
- 20 July 2001
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 14 (2), 141-146
- https://doi.org/10.1002/jmri.1164
Abstract
The aim of this study was to assess the time course and extent of signal alterations of red bone marrow after short‐term stimulation by recombinant human granulocyte‐colony stimulating factor (rHuG‐CSF) in healthy peripheral blood stem cell donors using magnetic resonance imaging (MRI) at low‐field strength. Twelve healthy blood stem cell donors without evidence of bone marrow disorders were prospectively investigated and underwent four MRI studies of their lumbar spine. Sagittal T1‐ and T2‐weighted spin‐echo sequences and a gradient‐echo (GE) sequence with an echo time for out‐of‐phase imaging were performed prior to rHuG‐CSF application (baseline MRI), on the day of first stem cell harvest (after 70 μg/kg body weight rHuG‐CSF, second MRI) followed by two studies 9–18 days (median 14.5 days, third MRI) and 26–48 days (median 39.5 days, fourth MRI) after discontinuation of rHuG‐CSF application. Baseline MRI showed normal marrow signal in all patients. The second MRI revealed a decrease of quantified bone marrow signal relative to nucleus pulposus in T1‐ and T2‐weighted images and an increase of relative signal in out‐of‐phase GE sequences. The greatest changes of relative marrow signal were observed at the third MRI. Compared to baseline MRI, relative marrow signal was diminished by 12% in T1‐weighted images and increased by 59% in GE sequences, consistent with a rise in marrow cellularity simulating diffuse marrow disease. At the fourth MRI quantified relative marrow signal returned to baseline levels in all sequences. In healthy individuals rHuG‐CSF application leads to significant signal changes of bone marrow in lumbar vertebra that are maximal about 2 weeks after discontinuation of rHuG‐CSF application. In patients with underlying marrow disorders who receive hematopoietic growth factors during treatment, these changes should not be confused with disease progression. J. Magn. Reson. Imaging 2001;14:141–146.Keywords
This publication has 24 references indexed in Scilit:
- Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.American Journal of Roentgenology, 1996
- MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor.American Journal of Roentgenology, 1995
- Fast spin‐echo MR imaging of the abdomen: Contrast optimization and artifact reductionJournal of Magnetic Resonance Imaging, 1994
- MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images.American Journal of Roentgenology, 1994
- Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging.Radiology, 1992
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Bone marrow imaging.Radiology, 1988
- Bone marrow in leukemia and aplastic anemia: MR imaging before, during, and after treatment.Radiology, 1987
- MRI in the detection of malignant infiltration of bone marrowAmerican Journal of Roentgenology, 1986
- Simple proton spectroscopic imaging.Radiology, 1984